Hollinshead A C, Chretien P B, Tarpley J L
IARC Sci Publ (1971). 1975(11 Pt 2):307-11.
The differences seen in levels of antibody response to HSV-TAA between non-laryngeal and laryngeal cancers in cured and untreated patient populations were due to the use of filtered sera. In previous and present studies using unfiltered sera, these differences were not noted. Of unfiltered sera from patients with squamous-cell carcinomas of the head and neck, 89% (49 out of 55) were positive for CF reactivity to HSV-TAA, and 44% of these unfiltered sera had titres of 1:4 or greater to 44 microng of antigen. The upper band of the antigen appears to be present in early provirus formation and is highly unstable whereas the lower band does not seem to be part of the assembly process.
在已治愈和未治愈患者群体中,非喉癌和喉癌患者对单纯疱疹病毒肿瘤相关抗原(HSV-TAA)的抗体反应水平差异是由于使用了过滤血清。在之前和目前使用未过滤血清的研究中,未发现这些差异。在头颈部鳞状细胞癌患者的未过滤血清中,89%(55份中的49份)对HSV-TAA的补体结合反应呈阳性,其中44%的未过滤血清对抗原的滴度为1:4或更高,抗原量为44微克。抗原的上带似乎存在于早期前病毒形成过程中,且高度不稳定,而下带似乎不是组装过程的一部分。